Other
Neoplasm by Obsolete Classification
CI-CAN-00000033Explore in graph →
Non-malignant11 active trials5 evidence items
- NCIt
- C45230
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000033Explore in graph →
Clinical trials
51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03016091 | A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma | terminated | Phase 2 | 18 | Rabin Medical CenterOTHER | 1 | Feb 18, 2025 | clinicaltrials |
| NCT03670069 | Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas | terminated | Phase 1 | 27 | Fred Hutchinson Cancer CenterOTHER | 1 | May 8, 2024 | clinicaltrials |
| terminated |
| Phase 1 |
| 26 |
| Fred Hutchinson Cancer CenterOTHER |
| 1 |
| Feb 9, 2023 |
| clinicaltrials |
| NCT01957709 | Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma | terminated | Early Phase 1 | 8 | Fred Hutchinson Cancer CenterOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT01525706 | Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm | terminated | Phase 1 | 1 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Nov 2, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Feb 18, 2025source: clinicaltrials